New Valley Fever drug developed at University of Arizona shows promise; vaccine still ahead

A new drug developed at the University of Arizona’s Valley Fever Center for Excellence could be a game changer for severe cases of Valley Fever. Olorofim is in its second clinical trial, with hopes to move toward FDA review this year.

“I have a few patients on that medication alone, and they are doing great,” Donovan said.